I know you are familiar with GILTF and its products and ventures. The company has very promising business plan,current sales and profits(EPS for 2001 is estimated to $2.7). Many reasons to invest in GILTF
are estimated to be .26 cents per share as per the merrill and saloman research reports. The reduced earnings are due to the fact that Gilat is selling to GTH at a reduced margin in lieu of an equity contribution. The concern should be that they beat that number as that is what is out there with all the revised brokerage estimates. Personally I think the company is being very conservative and will easily beat the number. In addition I think the top line revenue growth will come in ahead of the projected 85 million which is being watched more closely by analysts lately.